Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Panchsheel Organics Ltd Stock Analysis

Small Cap
Evaluated by 219 users | BSE: 531726 | NSE: PANCHSHEEL |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed 5.78%10.6%8.15%10.06%9.83%12.75%12.69%13.01%12.69%14.86%12.7%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 26.429.933.439.235.840.440.142.448.250.549.555
Y-o-Y Gr. Rt.-13.4%11.6%17.3%-8.6%12.8%-0.7%5.7%13.8%4.7%-2%-
Adjusted EPS (Rs.) 0.71.811.321.771.892.863.23.74.035.344.965.67
Y-o-Y Gr. Rt.-158.6%-27.1%34.1%6.8%51.3%11.9%15.6%8.9%32.5%-7.1%-
Book Value per Share (Rs.) 13.7215.5315.9817.4518.4520.8223.3726.8930.3935.239.5685.85
Adjusted Net Profit 0.71.81.31.81.92.93.23.745.456
Net Op. Cash Flow (Rs. Cr.) 2.41.40.73.51.134.63.12.54.65.3-
Debt to Cash Flow from Ops 2.723.859.431.575.911.651.461.851.970.940.71-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Panchsheel Organics Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 5.8%4.2%5.3%-2%
Adjusted EPS 11.9%11.6%10.3%-7.1%
Book Value per Share 1113.713.712.4
Share Price 30% 17% 53.9% 222%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) 5.2812.388.3710.5810.5214.5814.4814.7314.0816.2913.269.04
Operating Profit Margin (%) 8.9310.5110.4511.4113.3814.0316.6516.3614.3917.1117.417.7
Net Profit Margin (%) 2.686.073.964.535.297.118.018.768.3810.6110.0510.42
Debt to Equity 0.470.350.40.310.360.240.290.210.160.120.090.03
Working Capital Days 238235242231256231250285280287330313
Cash Conversion Cycle 144136132125151153165183181188188216
Loading price chart...
Entity Percentage Holding
Promoters 68.22%
Non-Institutions 31.78%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Panchsheel Organics Ltd's earnings have grown by 11.6%, whereas share price has appreciated 17% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Panchsheel Organics Ltd share price has appreciated 30% annually (CAGR) over the past ten years.

Data is not available for this company.

Panchsheel Organics, incorporated in the year 1989, is a part of the Pharmaceutical Division of the Turakhia Brothers Group. Turakhia Brothers was founded in 1975 in the Mumbai, India. The Turakhia Group, promoters of the company, are engaged in the import-export trade of pharmaceutical raw materials since the past 25 years.

Panchsheel exports bulk actives to over 60 countries mainly in Europe, South East Asia, Japan and Latin America. The company's inherent strength lies in identifying

Panchsheel Organics, incorporated in the year 1989, is a part of the Pharmaceutical Division of the Turakhia Brothers Group. Turakhia Brothers was founded in 1975 in the Mumbai, India. The Turakhia Group, promoters of the company, are engaged in the import-export trade of pharmaceutical raw materials since the past 25 years.

Panchsheel exports bulk actives to over 60 countries mainly in Europe, South East Asia, Japan and Latin America. The company's inherent strength lies in identifying relevant bulk drugs and selling them at affordable prices across the world.

Skilled people, modern equipment and broad experience contribute to the strength of Panchsheel Organics. Skilled production teams assure flexibility, efficiency and consistent standard in drugs manufacturing.

The R & D division of Panchsheel backed with experienced, highly qualified  teams provide sophisticated innovative solutions. Skilled production teams assure flexibility, efficiency and consistent standard in chemical manufacturing.

The current practices at Panchsheel are adherence to high quality and safety standards as well as full compliance with GMP procedures. The gaseous emissions are properly controlled and waste water is treated properly so as to ensure compliance with local and international risk, minimizing damage to persons and environment.

Panchsheel has free capacity in its five production sites in all over India. This capacity is would be used by interested companies for development and custom synthesis on strictly confidential terms.

Some of the basic operations carried out by Panchsheel are:

  • Hydrolysis
  • Condensation
  • Oxidation
  • Hydrogenation
  • Friedel Crafts
  • Grignard
  • Esterification
  • Nitration

Product range of the company includes:

  • Bulk Drugs - Alendronate Sodium Trihydrate,  Isoxsuprine HCL, Alprazolam, Itraconazole Pellets 22%, Amitriptyline HCL BP/USP, Ketoconazole BP/USP, Amlodipine Besylate etc.
  • Bittering Agent
  • Novel Drug Delivery System
  • Phytochemicals & Herbal Products
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback